METOLAZONE Side Effects

6991722-7 | Dehydration
on Sep 15, 2010 Female patient from UNITED STATES , weighting 32.41 lb, was diagnosed with sleep disorder (What is sleep disorder?) and was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration. Metolazone dosage: 1 Hs Prn Sleep Po. Patient was hospitalized.

6968943-2 | Azotaemia, Cellulitis, Dehydration, Renal Failure Acute
Patient was taking Metolazone (View Usage). Patient had the following side effects: azotaemia, cellulitis (What is cellulitis?), dehydration, renal failure acute on Sep 03, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 300.0 lb, was diagnosed with hypertension and. Metolazone dosage: 5 Mg Every Day Po. Patient was hospitalized.

6933052-5 | Abdominal Pain Upper, Flank Pain, Hunger, Nausea, Pancreatitis, Renal Failure Acute, Upper Respiratory Tract Infection
Adverse event was reported on Aug 18, 2010 by a Male patient taking Metolazone (View Usage) (Dosage: 5mg Daily As Needed Oral) was diagnosed with cardiac failure, weight increased, upper respiratory tract infection and. Location: UNITED STATES , 57 years of age, weighting 300.7 lb, After Metolazone was administered, patient had the following side effects: abdominal pain upper, flank pain, hunger, nausea (What is nausea?), pancreatitis, renal failure acute, upper respiratory tract infection. During the same period patient was treated with TETRACYCLINE (View Tetracycline Review and Tetracycline Label ), FEXOFENADINE HCL (View Fexofenadine Hcl Review and Fexofenadine Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MONTELUKAST SODIUM (View Montelukast Sodium Review and Montelukast Sodium Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MELOLAZONE (View Melolazone Review and Melolazone Label ). Patient was hospitalized.

6765082-0 | Loss Of Consciousness, Renal Failure
on Jun 09, 2010 Male patient from UNITED STATES , 62 years of age, weighting 203.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: loss of consciousness, renal failure. Metolazone dosage: 5 Mg Am Po. Patient was hospitalized.


6756968-1 | Confusional State, Dizziness, Hypotension, Renal Failure Acute
on Jun 03, 2010 Male patient from UNITED STATES , 64 years of age, weighting 162.0 lb, was treated with Metolazone (View Usage). Patient had the following side effects: confusional state, dizziness (What is dizziness?), hypotension, renal failure acute. Metolazone dosage: 2.5 Mg Every Day Po. During the same period patient was treated with BUMETANIDE (1 Tab Bid Po) (View Bumetanide Review and Bumetanide Label ). Patient was hospitalized.

6715968-8 | Cardiac Disorder, Fluid Retention, Joint Swelling, Memory Impairment, Muscular Weakness, Musculoskeletal Pain, Pain In Extremity, Vision Blurred, Yellow Skin
Patient was taking Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: cardiac disorder, fluid retention, joint swelling, memory impairment, muscular weakness, musculoskeletal pain, pain in extremity, vision blurred, yellow skin on May 06, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 370.0 lb, was diagnosed with fluid retention and. Metolazone dosage: 5 Mg. 1 X Day. During the same period patient was treated with METFORMIN HYDROCHLORIDE (1000, Mg 1 X Day) (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

6680855-0 | Blood Potassium Decreased
Adverse event was reported on Apr 13, 2010 by a Male patient taking Metolazone (View Usage) (Dosage: One Daily Po) . Location: UNITED STATES , 58 years of age, weighting 240.0 lb, Patient experienced the following unwanted or unexpected effects: blood potassium decreased. During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), NIACIN (View Niacin Review and Niacin Label ), MORPHINE SUL (View Morphine Sul Review and Morphine Sul Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), WELCHOL (View Welchol Review and Welchol Label ), STENT (View Stent Review and Stent Label ). Patient was hospitalized and became disabled.

6672631-X | Acute Coronary Syndrome, Acute Myocardial Infarction, Aortic Disorder, Arteriosclerosis, Blood Glucose Increased, Blood Potassium Decreased, Chest Discomfort, Dilatation Ventricular, Dyspnoea
on Mar 25, 2010 Male patient from UNITED STATES , weighting 262.4 lb, was diagnosed with cardiovascular disorder and was treated with Metolazone (View Usage). Patient had the following side effects: acute coronary syndrome, acute myocardial infarction, aortic disorder, arteriosclerosis, blood glucose increased, blood potassium decreased, chest discomfort, dilatation ventricular, dyspnoea. Metolazone dosage: . During the same period patient was treated with ALISKIREN (View Aliskiren Review and Aliskiren Label ), LASIX (View Lasix Review and Lasix Label ), VICODIN (View Vicodin Review and Vicodin Label ), ECOTRIN (View Ecotrin Review and Ecotrin Label ), DOXAZOSIN (View Doxazosin Review and Doxazosin Label ), LESCOL XL (View Lescol Xl Review and Lescol Xl Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized and became disabled.

6601928-4 | Acute Coronary Syndrome, Aortic Arteriosclerosis, Aortic Disorder, Blood Creatine Phosphokinase Increased, Blood Glucose Increased, Blood Sodium Decreased, Bundle Branch Block Right, Coronary Artery Stenosis, Disease Progression
on Feb 08, 2010 Male patient from UNITED STATES , weighting 262.4 lb, was diagnosed with cardiovascular disorder and was treated with Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: acute coronary syndrome, aortic arteriosclerosis, aortic disorder, blood creatine phosphokinase increased, blood glucose increased, blood sodium decreased, bundle branch block right, coronary artery stenosis, disease progression. Metolazone dosage: . During the same period patient was treated with ALISKIREN (View Aliskiren Review and Aliskiren Label ), LASIX (View Lasix Review and Lasix Label ), VICODIN (View Vicodin Review and Vicodin Label ), ECOTRIN (View Ecotrin Review and Ecotrin Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), LESCOL XL (View Lescol Xl Review and Lescol Xl Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized and became disabled.

6595614-7 | Agranulocytosis
Patient was taking Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis on Feb 22, 2010 from UNITED STATES Additional patient health information: Female patient , 83 years of age, weighting 172.0 lb, was diagnosed with acute prerenal failure, oedema and. Metolazone dosage: 2.5mg Bid Peg 8/23.

6581876-9 | Abasia, Asthenia, Hiccups, Hyponatraemia, Nausea
Adverse event was reported on Feb 12, 2010 by a Male patient taking Metolazone (View Usage) (Dosage: 2.5 Mg Other Po) . Location: UNITED STATES , 72 years of age, weighting 207.7 lb, Patient had the following side effects: abasia, asthenia, hiccups, hyponatraemia, nausea (What is nausea?). Patient was hospitalized.

6527765-7 | Azotaemia, Blood Sodium Decreased, Dehydration, Fatigue, Hypotension, Renal Disorder
on Dec 21, 2009 Male patient from DENMARK , 66 years of age, was treated with Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: azotaemia, blood sodium decreased, dehydration, fatigue, hypotension, renal disorder. Metolazone dosage: (2.5 Mg Qd). During the same period patient was treated with FUROSEMIDE ((40 Mg Tid), (), (dose Increased)) (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE ((12.5 Mg Qd)) (View Spironolactone Review and Spironolactone Label ), RAMIPRIL ((7.5 Mg, 5mg In The Morning And 2.5 Mg At Night), (dosage Adjusted)) (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6421882-8 | Arthropathy, Asthenia, Blood Potassium Decreased, Fatigue, Feeling Abnormal, Fibromyalgia, Hepatic Enzyme Increased, Pain
on Oct 29, 2009 Female patient from UNITED STATES , 46 years of age, weighting 195.0 lb, was diagnosed with hypertension, oedema and was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: arthropathy, asthenia, blood potassium decreased, fatigue, feeling abnormal, fibromyalgia, hepatic enzyme increased, pain (What is pain?). Metolazone dosage: One Daily Buccal.

6390181-5 | Angioedema, Dysphagia, Oropharyngeal Pain
Patient was taking Metolazone (View Usage). Patient had the following side effects: angioedema, dysphagia, oropharyngeal pain on Oct 05, 2009 from UNITED STATES Additional patient health information: Male patient , 57 years of age, was diagnosed with hypertension and. Metolazone dosage: 5 Mg Every Day Po.

6375675-0 | Asthenia, Blood Creatinine Increased, Blood Urea Increased, Hypokalaemia, Weight Decreased
Adverse event was reported on Sep 21, 2009 by a Male patient taking Metolazone (View Usage) (Dosage: 5 Mg Other Po) . Location: UNITED STATES , 85 years of age, weighting 176.4 lb, After Metolazone was administered, patient had the following side effects: asthenia, blood creatinine increased, blood urea increased, hypokalaemia, weight decreased. During the same period patient was treated with FUROSEMIDE (100 Mg Bid Po) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6371896-1 | Blood Glucose Increased, Blood Potassium Decreased, Blood Pressure Decreased, Loss Of Consciousness, Oxygen Saturation Decreased
on Sep 18, 2009 Male patient from UNITED STATES , 61 years of age, weighting 193.4 lb, was diagnosed with oedema and was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, blood potassium decreased, blood pressure decreased, loss of consciousness, oxygen saturation decreased. Metolazone dosage: 1 Tablet Daily For 7 Days Po. Patient was hospitalized.

6282704-1 | Hypokalaemia
on Jul 22, 2009 Male patient from UNITED STATES , 36 years of age, was treated with Metolazone (View Usage). Patient had the following side effects: hypokalaemia. Metolazone dosage: 5 Mg Prn Po. During the same period patient was treated with BUMETANIDE (3 Mg Tid Po) (View Bumetanide Review and Bumetanide Label ). Patient was hospitalized.

6252715-0 | Condition Aggravated, Hyponatraemia, Oedema Peripheral, Weight Increased
Patient was taking Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: condition aggravated, hyponatraemia, oedema peripheral, weight increased on Jun 29, 2009 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 194.0 lb, was diagnosed with oedema, renal failure chronic and. Metolazone dosage: 2.5 Mg Other Po. Patient was hospitalized.

6191176-7 | Bradycardia, Dehydration, Incorrect Dose Administered, Renal Failure Acute
Adverse event was reported on May 13, 2009 by a Male patient taking Metolazone (View Usage) (Dosage: 2.5 Mg Tid Po) was diagnosed with hypertension, oedema and. Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: bradycardia, dehydration, incorrect dose administered, renal failure acute. During the same period patient was treated with BUMETANIDE (2 Mg Tid Po) (View Bumetanide Review and Bumetanide Label ). Patient was hospitalized.

6178080-5 | Hypotension
on May 01, 2009 Male patient from UNITED STATES , 59 years of age, weighting 287.0 lb, was diagnosed with polyuria and was treated with Metolazone (View Usage). Patient had the following side effects: hypotension. Metolazone dosage: 2.5 Mg Other Po. Patient was hospitalized.

6104629-4 | Anorexia, Anuria, Asthenia, Blood Sodium Decreased, Disorientation, Dyspepsia, Nausea
on Feb 17, 2009 Male patient from UNITED STATES , 67 years of age, weighting 230.0 lb, was diagnosed with oedema peripheral and was treated with Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: anorexia, anuria, asthenia, blood sodium decreased, disorientation, dyspepsia, nausea (What is nausea?). Metolazone dosage: 2.5 Mg; Every Other Day; Oral; 5 Mg; X1;. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Oral) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LANTUS (View Lantus Review and Lantus Label ), NOVOLOG (View Novolog Review and Novolog Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ALTACE (View Altace Review and Altace Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6078428-6 | Anorexia, Asthenia, Blood Sodium Decreased, Disorientation, Dyspepsia, Nausea, Urine Output Decreased
Patient was taking Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: anorexia, asthenia, blood sodium decreased, disorientation, dyspepsia, nausea (What is nausea?), urine output decreased on Jan 29, 2009 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 230.0 lb, was diagnosed with oedema peripheral and. Metolazone dosage: 2.5 Mg;every Other Day;oral;5 Mg;x1;oral. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Oral) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6078428-6 | Anorexia, Asthenia, Blood Sodium Decreased, Disorientation, Dyspepsia, Nausea, Urine Output Decreased
Adverse event was reported on Jan 29, 2009 by a Male patient taking Metolazone (View Usage) (Dosage: 2.5 Mg;every Other Day;oral;5 Mg;x1;oral) was diagnosed with oedema peripheral and. Location: UNITED STATES , 67 years of age, weighting 230.0 lb, Patient had the following side effects: anorexia, asthenia, blood sodium decreased, disorientation, dyspepsia, nausea (What is nausea?), urine output decreased. During the same period patient was treated with FUROSEMIDE TABLETS, USP (Oral) (View Furosemide Tablets, Usp Review and Furosemide Tablets, Usp Label ). Patient was hospitalized.

5963275-3 | Dehydration, Hypokalaemia, Renal Failure Acute
on Nov 20, 2008 Male patient from UNITED STATES , 67 years of age, weighting 271.2 lb, was diagnosed with hypertension, oedema peripheral and was treated with Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: dehydration, hypokalaemia, renal failure acute. Metolazone dosage: 2.5 Mg Other Po. Patient was hospitalized.

5904474-6 | Hypokalaemia
on Sep 30, 2008 Female patient from UNITED STATES , 47 years of age, was diagnosed with cardiac failure congestive and was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia. Metolazone dosage: 2.5 Mg Every Day Po. During the same period patient was treated with FUROSEMIDE (80 Mg Bid Po) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5808535-1 | Hypokalaemia, Hypotension, Oedema Peripheral, Renal Failure Chronic
Patient was taking Metolazone (View Usage). Patient had the following side effects: hypokalaemia, hypotension, oedema peripheral, renal failure chronic on Jul 09, 2008 from UNITED STATES Additional patient health information: Male patient , 73 years of age, was diagnosed with cardiac failure congestive, hypertension and. Metolazone dosage: 2.5 Mg Every Day Po.

5805887-3 | Dehydration, Dizziness, Hypotension, Renal Failure Acute
Adverse event was reported on Jul 09, 2008 by a Male patient taking Metolazone (View Usage) (Dosage: 5 Mg Bid Po) was diagnosed with hypertension and. Location: UNITED STATES , 62 years of age, weighting 299.8 lb, After Metolazone was administered, patient had the following side effects: dehydration, dizziness (What is dizziness?), hypotension, renal failure acute.

5771808-5 | Condition Aggravated, Gout
on Jun 13, 2008 Male patient from UNITED STATES , 82 years of age, weighting 191.8 lb, was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, gout (What is gout?). Metolazone dosage: 1/2 Tab Every Day Po. Patient was hospitalized.

5763479-9 | Blister, Photosensitivity Reaction
on Jun 04, 2008 Male patient from UNITED STATES , 74 years of age, weighting 214.1 lb, was treated with Metolazone (View Usage). Patient had the following side effects: blister, photosensitivity reaction. Metolazone dosage: 2.5 Mg Other Po.

5726272-9 | Dehydration, Nausea
Patient was taking Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: dehydration, nausea (What is nausea?) on May 01, 2008 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with renal disorder and. Metolazone dosage: 5 Mg Bid Po. During the same period patient was treated with BUMETANIDE (1 Mg Bid Po) (View Bumetanide Review and Bumetanide Label ). Patient was hospitalized.

5689926-9 | Pancreatitis
Adverse event was reported on Mar 31, 2008 by a Male patient taking Metolazone (View Usage) (Dosage: 1tab Every Day Po) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 52 years of age, weighting 418.9 lb, Patient experienced the following unwanted or unexpected effects: pancreatitis. Patient was hospitalized.

5679297-6 | Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Hypokalaemia
on Mar 19, 2008 Male patient from UNITED STATES , 54 years of age, weighting 282.9 lb, was diagnosed with malignant hypertension and was treated with Metolazone (View Usage). Patient had the following side effects: blood creatinine increased, creatinine renal clearance decreased, hypokalaemia. Metolazone dosage: . During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), COREG (View Coreg Review and Coreg Label ), TEKTURNA (150 Mg, Qd) (View Tekturna Review and Tekturna Label ).

5650656-0 | Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Hypokalaemia
on Feb 29, 2008 Male patient from UNITED STATES , 54 years of age, weighting 282.9 lb, was diagnosed with malignant hypertension and was treated with Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: blood creatinine increased, creatinine renal clearance decreased, hypokalaemia. Metolazone dosage: . During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), COREG (View Coreg Review and Coreg Label ), TEKTURNA (150 Mg, Qd) (View Tekturna Review and Tekturna Label ).

5642851-1 | Blood Creatinine Increased, Creatinine Renal Clearance Decreased, Hypokalaemia
Patient was taking Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, creatinine renal clearance decreased, hypokalaemia on Feb 22, 2008 from UNITED STATES Additional patient health information: Male patient , 54 years of age, weighting 282.9 lb, was diagnosed with malignant hypertension and. Metolazone dosage: . During the same period patient was treated with NICARDIPINE HYDROCHLORIDE (View Nicardipine Hydrochloride Review and Nicardipine Hydrochloride Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), COREG (View Coreg Review and Coreg Label ), TEKTURNA (150 Mg, Qd) (View Tekturna Review and Tekturna Label ).

5622639-8 | Confusional State, Hypokalaemia
Adverse event was reported on Feb 11, 2008 by a Male patient taking Metolazone (View Usage) (Dosage: 2.5mg Every Day Po) . Location: UNITED STATES , 53 years of age, Patient had the following side effects: confusional state, hypokalaemia. During the same period patient was treated with FUROSEMIDE (80mg Every Day Po) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5598178-X | Renal Failure
on Jan 17, 2008 Male patient from UNITED STATES , 74 years of age, weighting 189.6 lb, was diagnosed with cardiac failure congestive and was treated with Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: renal failure. Metolazone dosage: 10mg Bid Po. During the same period patient was treated with LISINOPRIL (10mg Every Day Po) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5536090-2 | Blood Glucose Increased, Constipation, Contusion, Dehydration, Dizziness, Fall, Headache, Loss Of Consciousness, Nausea
on Nov 20, 2007 Male patient from UNITED STATES , 84 years of age, was diagnosed with oedema and was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, constipation (What is constipation?), contusion, dehydration, dizziness (What is dizziness?), fall (What is fall?), headache (What is headache?), loss of consciousness, nausea (What is nausea?). Metolazone dosage: 2.5 Mg; Every Other Day; Oral. During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), DIOVAN (View Diovan Review and Diovan Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

5509959-2 | Hypokalaemia, Muscle Spasms
Patient was taking Metolazone (View Usage). Patient had the following side effects: hypokalaemia, muscle spasms on Nov 07, 2007 from UNITED STATES Additional patient health information: Female patient , 72 years of age, weighting 238.0 lb, was diagnosed with hypertension and. Metolazone dosage: 5mg Daily Po. During the same period patient was treated with CELOCOXIB (View Celocoxib Review and Celocoxib Label ), FLUTICAZONE/SALMETEROL (View Fluticazone/salmeterol Review and Fluticazone/salmeterol Label ), TYLENOL ACETAMINOPHEN ARTHRITIS (View Tylenol -acetaminophen- Arthritis Review and Tylenol -acetaminophen- Arthritis Label ), DOCUSATE (View Docusate Review and Docusate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

5305692-0 | Asthenia, Hyperhidrosis, Hypokalaemia, Nausea, Weight Decreased
Adverse event was reported on Apr 23, 2007 by a Male patient taking Metolazone (View Usage) (Dosage: 5mg Qam Po) . Location: UNITED STATES , 59 years of age, After Metolazone was administered, patient had the following side effects: asthenia, hyperhidrosis, hypokalaemia, nausea (What is nausea?), weight decreased. During the same period patient was treated with FUROSEMIDE (40m Daily Po) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5276878-9 | Hypotension, Malaise, Shock, Syncope, Vomiting
on Dec 22, 2005 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with oedema, blood pressure (What is blood pressure?) and was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, malaise, shock, syncope, vomiting. Metolazone dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ISPAGHULA HUSK (View Ispaghula Husk Review and Ispaghula Husk Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ISMN (View Ismn Review and Ismn Label ). Patient was hospitalized.

5272133-1 | Rash Erythematous
on Mar 20, 2007 Male patient from UNITED STATES , 69 years of age, weighting 194.0 lb, was diagnosed with fluid retention and was treated with Metolazone (View Usage). Patient had the following side effects: rash erythematous. Metolazone dosage: 1 Tablet Once Daily Po.

5242346-3 | Hypotension
Patient was taking Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: hypotension on Feb 16, 2007 from UNITED STATES Additional patient health information: Male patient , 64 years of age, . Metolazone dosage: 5 Mg Bid. During the same period patient was treated with BUMETANIDE (1 Mg Qd) (View Bumetanide Review and Bumetanide Label ), SPIRONOLACTONE (100 Mg Bid) (View Spironolactone Review and Spironolactone Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), MG OXIDE (View Mg Oxide Review and Mg Oxide Label ), SENOKOT (View Senokot Review and Senokot Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

5146692-3 | Angioneurotic Oedema, Laryngeal Oedema
Adverse event was reported on Nov 07, 2006 by a Male patient taking Metolazone (View Usage) (Dosage: 2.5 Mg Every 12 Hours Po) was diagnosed with polyuria and. Location: UNITED STATES , weighting 222.7 lb, Patient experienced the following unwanted or unexpected effects: angioneurotic oedema, laryngeal oedema. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), THIAMINE (View Thiamine Review and Thiamine Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), DOCUSATE (View Docusate Review and Docusate Label ), OCTREOTIDE ACETATE (View Octreotide Acetate Review and Octreotide Acetate Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5139868-2 | Renal Failure Acute
on Oct 26, 2006 Male patient from UNITED STATES , weighting 328.5 lb, was diagnosed with cardiac failure congestive and was treated with Metolazone (View Usage). Patient had the following side effects: renal failure acute. Metolazone dosage: 2.5mg Daily Po. During the same period patient was treated with FUROSEMIDE (200mg Daily Po) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5120755-0 | Confusional State, Hyponatraemia, Lethargy
on Oct 03, 2006 Male patient from UNITED STATES , 60 years of age, was diagnosed with oedema and was treated with Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: confusional state, hyponatraemia, lethargy. Metolazone dosage: 2.5 Mg Q Am. Patient was hospitalized.

5093867-8 | Asthenia, Dyspnoea, Medical Diet, Polyuria, Renal Failure Acute
Patient was taking Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dyspnoea, medical diet, polyuria, renal failure acute on Aug 29, 2006 from UNITED STATES Additional patient health information: Male patient , weighting 249.1 lb, was diagnosed with cardiac failure congestive and. Metolazone dosage: 2.5mg Mon And Fri Po. Patient was hospitalized.

5071541-1 | Renal Failure Chronic
Adverse event was reported on Aug 03, 2006 by a Male patient taking Metolazone (View Usage) (Dosage: 2.5 Mg Po Every Other Day) was diagnosed with oedema, hypertension and. Location: UNITED STATES , 85 years of age, weighting 184.1 lb, Patient had the following side effects: renal failure chronic. During the same period patient was treated with FUROSEMIDE (80 Mg Po Daily) (View Furosemide Review and Furosemide Label ), LISINOPRIL (5 Mg Po Daily) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

5061187-3 | Asthenia, Dehydration, Polyuria, Renal Failure Acute
on Jul 19, 2006 Male patient from UNITED STATES , 83 years of age, was diagnosed with fluid retention and was treated with Metolazone (View Usage). After Metolazone was administered, patient had the following side effects: asthenia, dehydration, polyuria, renal failure acute. Metolazone dosage: 25 Mg Po Qd. Patient was hospitalized.

5015924-4 | Chest Pain, Dyspnoea, Hypokalaemia
on May 31, 2006 Male patient from UNITED STATES , 69 years of age, weighting ***** lb, was treated with Metolazone (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea, hypokalaemia. Metolazone dosage: . During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), WARFARIN (View Warfarin Review and Warfarin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

5015840-8 | Chest Pain, Hypokalaemia, Weight Decreased
Patient was taking Metolazone (View Usage). Patient had the following side effects: chest pain (What is chest pain?), hypokalaemia, weight decreased on May 31, 2006 from UNITED STATES Additional patient health information: Male patient , 69 years of age, weighting 223.0 lb, . Metolazone dosage: 2.5 Mg 3/weekly. During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), WARFARIN (View Warfarin Review and Warfarin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).